KIMS receives NSE listing approval for 1.99 crore QIP equity shares at Rs. 2/- par

IPO / ECM 23 Jun 2026· ₹3.97 cr (nominal) · Completed· ✓ Verified

The NSE General Updates filing dated 23 June 2026 confirms receipt of listing approval for 1,98,67,549 shares at Rs. 2/- par value each through qualified institutional placement. The listing intimation confirms that the QIP mechanism has progressed to the post-allotment listing stage. QIPs under SEBI Regulations allow listed companies to raise capital from qualifying institutional investors (mutual funds, insurance companies, foreign institutional investors) without a public offering prospectus. The Rs. 2/- per share figure represents the nominal/par value; the actual subscription price would have been determined at the QIP pricing window and disclosed separately in the board/institutional…

Why it mattersQIP listing completion under Securities and Exchange Board of India (SEBI) QIP framework requires exchange approval before share allotment becomes effective; this NSE intimation signals final listing clearance and institutional subscription closure.
SectorPharma & Healthcare
Value₹3.97 cr (nominal)
[object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals